Evaluating the Feasibility of Performing Window of Opportunity Trials in Breast Cancer

Figure 3

Ki67 labelling index (a) and cleaved caspase 3 (CC3) (b) at baseline and after anastrozole treatment at surgery.

(a)

(b)